Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

ERYTECH Pharma S.A. - Filing #858938

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
1 402 EUR
1 215 EUR
1 744 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
3 177 EUR
26 720 EUR
30 770 EUR
Current assets
42 634 EUR
40 048 EUR
49 632 EUR
Non-current liabilities
10 646 EUR
23 918 EUR
24 516 EUR
Current liabilities
11 678 EUR
20 005 EUR
29 347 EUR
Profit (loss)
228,000 EUR
228,000 EUR
53 797 EUR
53 797 EUR
73 300 EUR
73 300 EUR
Other comprehensive income
422,000 EUR
235,000 EUR
EUR
187,000 EUR
68,000 EUR
528,000 EUR
460,000 EUR
381,000 EUR
19,000 EUR
400,000 EUR
Comprehensive income
EUR
194,000 EUR
235,000 EUR
228,000 EUR
EUR
187,000 EUR
53 797 EUR
EUR
68,000 EUR
528,000 EUR
EUR
54 257 EUR
72 919 EUR
19,000 EUR
73 300 EUR
EUR
400,000 EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.